美股周一早盘，生物制药公司Vivani Medical（VANI）股价下跌5.9%，此前该公司宣布以每股1.62美元完成1600万美元募资，所筹资金将用于研发。此次发行包括私募配售，表明对公司发展的战略投资。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：张俊 SF065

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.